Create a presentation based on the document.
Create a presentation based on the document.
Created using ChatSlide
This presentation provides an in-depth analysis of a phase 2 study of Ceperognastat, targeting Alzheimer's disease with tau pathology. Key topics include the drugβs role in tau accumulation, detailed study design, and intervention specifics with randomised, double-blind methods across 72 global sites. The study's efficacy and safety objectives focus on clinical measures such as iADRS and ADAS-Cog13 scores. Despite a substantial trial population of 327, results indicated no significant benefit...